Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Active not recruiting 5Recruiting 3Not yet recruiting 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Gynecologic 1

Conditions

Breast Neoplasms 362Neoplasms 258Carcinoma, Non-Small-Cell Lung 201Colorectal Neoplasms 183Lung Neoplasms 152Prostatic Neoplasms 151Carcinoma, Hepatocellular 129Leukemia, Myeloid, Acute 96Pancreatic Neoplasms 86Multiple Myeloma 84Neoplasm Metastasis 74Recurrence 72Uterine Cervical Neoplasms 69Rectal Neoplasms 68Stomach Neoplasms 65Ovarian Neoplasms 65Triple Negative Breast Neoplasms 61Squamous Cell Carcinoma of Head and Neck 57Head and Neck Neoplasms 56Brain Neoplasms 56Glioblastoma 55Precursor Cell Lymphoblastic Leukemia-Lymphoma 51Small Cell Lung Carcinoma 50Endometrial Neoplasms 46Melanoma 45Esophageal Neoplasms 43Disease 43Glioma 42Colonic Neoplasms 42Hematologic Neoplasms 41

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Anal Canal Carcinoma × 1 year × Clear all
NCT07523152 2026-04-13

SAPPHIRE

Institut du Cancer de Montpellier - Val d'Aurelle

Phase NA Not yet recruiting
42 enrolled
GastrointestinalGynecologic

Anal Canal Carcinoma, Anus Neoplasms, Pelvic Neoplasms, Uterine Neoplasms, Vaginal Neoplasms

NCT07059442 2025-07-10

SANCA

Karolinska Institutet

Phase NA Not yet recruiting
1,000 enrolled
Gastrointestinal

Anal Canal Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡